112 related articles for article (PubMed ID: 462860)
1. [Experimental data to substantiate the antitumor action of hydrazine sulfate].
Tret'iakov AV; Filov VA; Riazanov EM; Tarkov AS
Vopr Onkol; 1979; 25(6):100-3. PubMed ID: 462860
[TBL] [Abstract][Full Text] [Related]
2. [Selective action of hydrazine sulfate in combination with thiophosphamide on tumor cell mitochondria].
Tret'iakov AV; Golovatova VA; Filov VA
Vopr Onkol; 1982; 28(3):86-8. PubMed ID: 6461132
[TBL] [Abstract][Full Text] [Related]
3. [Experimental and clinical data on the antitumor action of hydrazine sulfate].
Seĭts IF; Gershanovich ML; Filov VA; Danova LA; Kondrat'ev VB
Vopr Onkol; 1975; 21(1):45-52. PubMed ID: 1090085
[No Abstract] [Full Text] [Related]
4. Potentiation by clofibrate of in-vivo tumor inhibition by hydrazine sulfate and cytotoxic agents, in Walker 256 carcinosarcoma.
Gold J
Cancer Biochem Biophys; 1978; 3(1):41-5. PubMed ID: 552898
[TBL] [Abstract][Full Text] [Related]
5. [Experimental data on the toxic action of hydrazine sulfate on the body and on a tumor].
Filov VA; Stukov AN; Blank MA; Neĭshtadt EL
Farmakol Toksikol; 1978; 41(2):203-5. PubMed ID: 658367
[TBL] [Abstract][Full Text] [Related]
6. Enhancement by hydrazine sulfate of antitumor effectiveness of cytoxan, mitomycin C, methotrexate and bleomycin, in walker 256 carcinosarcoma in rats.
Gold J
Oncology; 1975; 31(1):44-53. PubMed ID: 51492
[TBL] [Abstract][Full Text] [Related]
7. On the relationship between the activity of acetylation, growth of experimental tumors and efficacy of their suppression by hydrazine sulphate.
Dilman VM; Anisimov VN; Kolosov AI; Bulovskaya LN
Oncology; 1976; 33(5-6):219-21. PubMed ID: 1026855
[TBL] [Abstract][Full Text] [Related]
8. [Gluconeogenesis during therapy of experimental tumors with hydrazine sulfate].
Filov VA; Burova TM
Biull Eksp Biol Med; 1984 Jan; 97(1):73-4. PubMed ID: 6692028
[TBL] [Abstract][Full Text] [Related]
9. [Action of hydrazine sulfate on energy metabolism and glycogen synthesis in animal liver and tumor cells].
Misheneva VS; Burova TM; Goriukhina TA
Vopr Onkol; 1980; 26(2):95-7. PubMed ID: 7361502
[No Abstract] [Full Text] [Related]
10. Antitumor effect of N alpha-benzyloxycarbonyl-N,N-bis-(2-halogenethyl)-hydrazide derivatives of amino acids.
Karaivanova MH; Zakhariev SG; Golovinsky EV
Neoplasma; 1980; 27(2):137-42. PubMed ID: 7393353
[TBL] [Abstract][Full Text] [Related]
11. [Effect of hydrazine sulfate on nucleic acid metabolism in rat liver tissue during the process of chemical hepatocarcinogenesis].
Voronova LA; Ivanov SD; Zabezhinskiĭ MA
Vopr Onkol; 1980; 26(2):58-62. PubMed ID: 7361495
[TBL] [Abstract][Full Text] [Related]
12. [Screening of substances and extracts of plant origin in Walker carcinosarcoma 256].
Sampaio MR; De Oliveira MM
An Acad Bras Cienc; 1975; 47(1):149-53. PubMed ID: 1233885
[TBL] [Abstract][Full Text] [Related]
13. [Effect high-altitude conditions on the antitumor activity of cyclophosphane and its action on lymphoid tissue cells].
Kulish OP
Eksp Onkol; 1985; 7(3):60-3. PubMed ID: 3160572
[TBL] [Abstract][Full Text] [Related]
14. [Kinetic study of the effectiveness of chemotherapy of experimental metastases (using a computer)].
Emanuél NM; Kiseleva EG; Sushchenko VV; D'iachkovskaia RF; Volkova LM
Vopr Onkol; 1977; 23(8):64-8. PubMed ID: 198956
[TBL] [Abstract][Full Text] [Related]
15. [Paramagnetic diethyleneimides of urethane phosphoric acids as antitumor agents].
Emanuél' NM; Zhdanov RI; Konovalova NP; Vasil'eva LS; Buina NA
Vopr Onkol; 1980; 26(5):54-8. PubMed ID: 6247836
[TBL] [Abstract][Full Text] [Related]
16. Antineoplastic activity of new linear hydrazine derivatives.
Fiszer-Maliszewska L; Peczyńska-Czoch W; Wieczorek J; Mordarski M; Balicki R; Nantka-Namirski P
Arch Immunol Ther Exp (Warsz); 1987; 35(2):225-35. PubMed ID: 3447537
[TBL] [Abstract][Full Text] [Related]
17. [Enhancement of the antitumor effect of cyclophosphane in an experiment].
Chissov VI; Rusakov IG; Shchitkov KG; Igitov VI; Solodovnik VD
Vopr Onkol; 1985; 31(12):80-6. PubMed ID: 4082511
[TBL] [Abstract][Full Text] [Related]
18. [The results of a clinical study of the preparation hydrazine sulfate].
Filov VA; Danova LA; Gershanovich ML; Ivin BA; Dement'eva NP; Breĭvis PV; Ragaĭshene VP; Kas'ianenko IV; Lisitsa AM; Mindlin SS
Vopr Onkol; 1990; 36(6):721-6. PubMed ID: 2198698
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by hydrazine sulfate and various hydrazides, of in vivo growth of Walker 256 intramuscular carcinoma, B-16 melanoma, Murphy-Sturm lymphosarcoma and L-1210 solid leukemia.
Gold J
Oncology; 1973; 27(1):69-80. PubMed ID: 4739164
[No Abstract] [Full Text] [Related]
20. Clinical data on the antitumor activity of hydrazine sulfate.
Gershanovich ML; Danova LA; Kondratyev VB; Malyugina LL; Stukov AN; Seitz JF; Filov VA
Cancer Treat Rep; 1976 Jul; 60(7):933-5. PubMed ID: 1009524
[No Abstract] [Full Text] [Related]
[Next] [New Search]
